These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 20088742)
41. Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis. Yue X; Lin X; Yang T; Yang X; Yi X; Jiang X; Li X; Li T; Guo J; Dai Y; Shi J; Wei L; Youker KA; Torre-Amione G; Yu Y; Andrade KC; Chang J Hypertension; 2016 Mar; 67(3):597-605. PubMed ID: 26781283 [TBL] [Abstract][Full Text] [Related]
42. Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors. Vuorio T; Jauhiainen S; Ylä-Herttuala S Expert Opin Biol Ther; 2012 Jan; 12(1):79-92. PubMed ID: 22115316 [TBL] [Abstract][Full Text] [Related]
43. Coronary angiogenic effect of long-term administration of Nigella sativa. Al Asoom LI BMC Complement Altern Med; 2017 Jun; 17(1):308. PubMed ID: 28610577 [TBL] [Abstract][Full Text] [Related]
44. Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review. Kusumanto YH; Hospers GA; Mulder NH; Tio RA Int J Cardiovasc Intervent; 2003; 5(1):27-34. PubMed ID: 12623562 [TBL] [Abstract][Full Text] [Related]
45. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients. Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954 [TBL] [Abstract][Full Text] [Related]
46. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma. Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994 [TBL] [Abstract][Full Text] [Related]
47. The Role of CC-Chemokines in the Regulation of Angiogenesis. Ridiandries A; Tan JT; Bursill CA Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834814 [TBL] [Abstract][Full Text] [Related]
48. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. Zhao Y; Adjei AA Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391 [TBL] [Abstract][Full Text] [Related]
49. Therapeutic angiogenesis for revascularization in peripheral artery disease. Grochot-Przeczek A; Dulak J; Jozkowicz A Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831 [TBL] [Abstract][Full Text] [Related]
50. Angiogenic and Antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients. Li HM; Mo ZW; Peng YM; Li Y; Dai WP; Yuan HY; Chang FJ; Wang TT; Wang M; Hu KH; Li XD; Ning DS; Chen YT; Song YK; Lu XL; Pei Z; Dong YG; Wang ZP; Zhang X; Xu YQ; Wang SM; Ou ZJ; Ou JS Redox Biol; 2020 Sep; 36():101642. PubMed ID: 32863238 [TBL] [Abstract][Full Text] [Related]
51. Sequential Bone-Marrow Cell Delivery of VEGFA/S1P Improves Vascularization and Limits Adverse Cardiac Remodeling After Myocardial Infarction in Mice. Żak MM; Gkontra P; Clemente C; Squadrito ML; Ferrarini A; Mota RA; Oliver E; Rocha S; Agüero J; Vázquez J; De Palma M; Ibáñez B; Arroyo AG Hum Gene Ther; 2019 Jul; 30(7):893-905. PubMed ID: 30786776 [TBL] [Abstract][Full Text] [Related]
52. Prospects for therapeutic inhibition of neuroblastoma angiogenesis. Shusterman S; Maris JM Cancer Lett; 2005 Oct; 228(1-2):171-9. PubMed ID: 15927358 [TBL] [Abstract][Full Text] [Related]
53. Clinical use of intracoronary gene transfer of fibroblast growth factor for coronary artery disease. Penny WF; Hammond HK Curr Gene Ther; 2004 Jun; 4(2):225-30. PubMed ID: 15180588 [TBL] [Abstract][Full Text] [Related]